Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · IEX Real-Time Price · USD
74.31
+5.45 (7.91%)
At close: Apr 26, 2024, 4:00 PM
74.67
+0.36 (0.48%)
After-hours: Apr 26, 2024, 7:59 PM EDT
Viking Therapeutics Market Cap
Viking Therapeutics has a market cap or net worth of $8.13 billion as of April 26, 2024. Its market cap has increased by 387.18% in one year.
Market Cap
8.13B
Enterprise Value
7.16B
1-Year Change
387.18%
Ranking
Category
Stock Price
$74.31
Market Cap Chart
Since April 29, 2015, Viking Therapeutics's market cap has increased from $77.50M to $8.13B, an increase of 10,385.48%. That is a compound annual growth rate of 67.72%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 7.59B | 16.12% |
Apr 24, 2024 | 6.54B | 0.22% |
Apr 23, 2024 | 6.52B | 1.69% |
Apr 22, 2024 | 6.42B | 0.68% |
Apr 19, 2024 | 6.37B | -1.93% |
Apr 18, 2024 | 6.50B | -2.71% |
Apr 17, 2024 | 6.68B | -2.18% |
Apr 16, 2024 | 6.83B | 1.49% |
Apr 15, 2024 | 6.73B | -2.43% |
Apr 12, 2024 | 6.90B | -3.17% |
Apr 11, 2024 | 7.12B | -1.09% |
Apr 10, 2024 | 7.20B | -1.62% |
Apr 9, 2024 | 7.32B | -4.02% |
Apr 8, 2024 | 7.63B | -0.74% |
Apr 5, 2024 | 7.68B | 3.76% |
Apr 4, 2024 | 7.40B | -6.07% |
Apr 3, 2024 | 7.88B | 1.41% |
Apr 2, 2024 | 7.77B | -2.70% |
Apr 1, 2024 | 7.99B | -3.05% |
Mar 28, 2024 | 8.24B | -1.61% |
Mar 27, 2024 | 8.37B | 3.10% |
Mar 26, 2024 | 8.12B | 16.82% |
Mar 25, 2024 | 6.95B | -0.52% |
Mar 22, 2024 | 6.99B | -1.47% |
Mar 21, 2024 | 7.09B | -0.63% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Bio-Rad Laboratories | 7.98B |
Penumbra | 7.98B |
Bio-Rad Laboratories | 7.91B |
Cerevel Therapeutics Holdings | 7.61B |
Masimo | 7.19B |
Inspire Medical Systems | 7.10B |
Intra-Cellular Therapies | 7.08B |
Exelixis | 6.99B |